Hub : Traits :

Illnesses of father: Heart disease

67 significantly associated models · 20 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 109098737 110517617 3 1 4.1e-12 3.2e-12 1.0e+00 100 PSRC1
2 1 222096959 223537385 3 1 6.4e-09 5.5e-09 9.3e-02 92 AIDA
3 6 12020241 13990267 2 1 2.0e-10 1.1e-11 1.0e+00 100 RP1-257A7.5
4 6 160071844 161571560 2 2 7.4e-13 3.4e-14 1.1e-05 66 SLC22A1 SLC22A3
5 7 43719868 45228018 1 1 2.8e-08 1.7e-07 1.0e+00 100 NUDCD3
6 9 21303958 22819407 2 2 1.0e-20 3.3e-41 8.0e-21 52 CDKN2B CDKN2B-AS1
7 11 125979757 126556323 1 1 1.6e-08 1.0e-05 5.2e-03 60 ST3GAL4
8 15 78360691 79802863 2 2 6.7e-08 5.4e-07 1.9e-01 93 ADAMTS7 MORF4L1
9 15 90730363 92135418 1 1 8.5e-14 5.1e-11 9.7e-01 100 FES
10 16 81966047 84527021 1 1 2.8e-08 2.1e-08 1.6e-01 94 CDH13
11 17 1717695 2453908 1 1 1.7e-07 2.5e-08 1.0e-02 79 SMG6

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 3.12 2 1 2.2 0.00 1.0e+00 FES SMG6
Intelligence (Savage-Jansen 2018) 0.76 1 0 0.0 0.00 1.0e+00 NUDCD3
Neuroticism (Nagel 2018) 1.69 1 0 0.0 0.00 1.0e+00 SLC22A1
Schizophrenia (2018) 3.18 2 1 2.2 0.00 1.0e+00 FES SMG6
Worry (Nagel 2018) 1.14 1 0 0.0 0.00 1.0e+00 SLC22A1
Breast Cancer 2.23 3 0 0.0 0.00 1.0e+00 CDKN2B CDKN2B-AS1 FES
Coronary Artery Disease (CAD) 25.60 9 6 13.3 0.98 2.1e-06 ADAMTS7 CDKN2B CDKN2B-AS1 MORF4L1 PSRC1 RP1-257A7.5 SLC22A3 SMG6 ST3GAL4
HDL Cholesterol 2.20 2 0 0.0 0.00 1.0e+00 PSRC1 ST3GAL4
LDL Cholesterol 41.14 3 2 4.4 0.00 1.0e+00 NUDCD3 PSRC1 ST3GAL4
Schizophrenia (2014) 3.46 2 2 4.4 0.00 1.0e+00 FES SMG6
Type 2 Diabetes (T2D) (2012) 2.59 1 0 0.0 0.00 1.0e+00 CDKN2B
Blood Eosinophil Count 0.48 1 0 0.0 0.00 1.0e+00 ST3GAL4
Blood Platelet Count 2.72 5 2 4.4 0.53 3.6e-01 ADAMTS7 CDKN2B NUDCD3 SLC22A3 SMG6
Blood Red Count 0.61 3 0 0.0 0.00 1.0e+00 FES RP1-257A7.5 SMG6
Blood White Count 2.03 3 2 4.4 0.00 1.0e+00 CDKN2B FES SMG6
Heel T-Score 3.74 2 1 2.2 0.00 1.0e+00 PSRC1 SMG6
BMI 1.12 2 0 0.0 0.00 1.0e+00 SLC22A3 SMG6
Height 0.63 4 3 6.7 -0.75 2.5e-01 FES NUDCD3 PSRC1 SLC22A3
Waist Hip Ratio (WHR) 2.01 3 1 2.2 0.00 1.0e+00 ADAMTS7 SLC22A3 SMG6
Systolic Blood Pressure 6.31 6 3 6.7 0.65 1.6e-01 CDH13 FES MORF4L1 RP1-257A7.5 SLC22A3 ST3GAL4
Smoking Status 1.89 1 0 0.0 0.00 1.0e+00 FES
Allergy or Eczema 1.56 2 0 0.0 0.00 1.0e+00 FES SMG6
Cardiovascular Disease 7.34 5 3 6.7 0.98 4.6e-03 FES PSRC1 SLC22A1 SLC22A3 ST3GAL4
Respiratory disease 1.66 1 0 0.0 0.00 1.0e+00 FES
Lung FEV1/FVC ratio 2.30 3 2 4.4 0.00 1.0e+00 AIDA PSRC1 SMG6
Lung FVC 0.70 2 0 0.0 0.00 1.0e+00 AIDA NUDCD3
Neuroticism 1.56 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A1
Hair Pigment 0.44 4 3 6.7 -0.83 1.7e-01 ADAMTS7 CDKN2B CDKN2B-AS1 FES
Hand grip strength (left) 1.62 2 1 2.2 0.00 1.0e+00 FES RP1-257A7.5
Number of treatments/medications taken 3.43 2 1 2.2 0.00 1.0e+00 FES PSRC1
Sensitivity / hurt feelings 1.59 1 1 2.2 0.00 1.0e+00 FES
Relative age of first facial hair 1.27 1 0 0.0 0.00 1.0e+00 SMG6
Systolic blood pressure, automated reading 5.36 4 1 2.2 0.60 4.0e-01 CDH13 FES RP1-257A7.5 ST3GAL4
Angina 24.74 9 9 20.0 0.99 8.5e-08 ADAMTS7 CDKN2B CDKN2B-AS1 FES MORF4L1 PSRC1 RP1-257A7.5 SLC22A1 SLC22A3
Medication: Metformin 1.74 1 0 0.0 0.00 1.0e+00 CDKN2B
Pack years adult smoking proportion 5.26 2 2 4.4 0.00 1.0e+00 ADAMTS7 MORF4L1
Impedance of leg (right) 2.15 3 2 4.4 0.00 1.0e+00 AIDA FES SMG6
Leg fat-free mass (left) 1.53 4 1 2.2 -0.40 6.0e-01 FES NUDCD3 SLC22A3 SMG6
Trunk fat percentage 1.31 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Hand grip strength (right) 1.16 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Heel bone mineral density (BMD) T-score, automated (left) 2.95 1 1 2.2 0.00 1.0e+00 SMG6
High blood pressure 5.74 2 1 2.2 0.00 1.0e+00 FES SMG6
Hayfever, allergic rhinitis or eczema 1.50 1 0 0.0 0.00 1.0e+00 FES
Multivitamins +/- minerals 2.60 1 0 0.0 0.00 1.0e+00 MORF4L1
Medication: Atenolol 7.10 2 1 2.2 0.00 1.0e+00 FES PSRC1
Sitting height 0.68 3 0 0.0 0.00 1.0e+00 FES MORF4L1 SLC22A3
Chronic bronchitis/emphysema (father) 3.31 1 0 0.0 0.00 1.0e+00 ADAMTS7
High blood pressure (mother) 6.23 2 1 2.2 0.00 1.0e+00 FES RP1-257A7.5
Body mass index (BMI) 1.03 1 0 0.0 0.00 1.0e+00 SMG6
Impedance of leg (left) 2.10 3 2 4.4 0.00 1.0e+00 AIDA FES SMG6
Leg predicted mass (left) 1.53 5 1 2.2 -0.40 5.1e-01 FES NUDCD3 PSRC1 SLC22A3 SMG6
Trunk fat mass 1.41 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Waist circumference 1.15 1 0 0.0 0.00 1.0e+00 SMG6
Number of incorrect matches in round 1.36 1 0 0.0 0.00 1.0e+00 FES
Past tobacco smoking 2.07 1 0 0.0 0.00 1.0e+00 CDKN2B-AS1
Alcohol usually taken with meals 1.95 1 0 0.0 0.00 1.0e+00 FES
Hair/balding pattern: Pattern 2 1.39 1 0 0.0 0.00 1.0e+00 SMG6
Had other major operations 1.98 1 0 0.0 0.00 1.0e+00 NUDCD3
Heel bone mineral density (BMD) T-score, automated (right) 2.53 1 1 2.2 0.00 1.0e+00 SMG6
Heart attack 21.39 8 8 17.8 0.99 2.5e-06 AIDA CDKN2B CDKN2B-AS1 FES PSRC1 RP1-257A7.5 SLC22A1 SLC22A3
Allergy 1.28 1 0 0.0 0.00 1.0e+00 FES
Medication: Ramipril 4.07 1 0 0.0 0.00 1.0e+00 FES
Medication: Simvastatin 13.46 7 2 4.4 0.91 4.4e-03 CDKN2B CDKN2B-AS1 FES PSRC1 SLC22A1 SLC22A3 ST3GAL4
Illnesses of siblings 4.03 2 1 2.2 0.00 1.0e+00 FES SMG6
Weight 1.42 3 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3 SMG6
Impedance of arm (right) 1.19 1 1 2.2 0.00 1.0e+00 SMG6
Arm fat percentage (right) 1.43 1 0 0.0 0.00 1.0e+00 NUDCD3
Trunk fat-free mass 1.39 3 2 4.4 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Hip circumference 1.47 4 1 2.2 -0.62 3.8e-01 ADAMTS7 NUDCD3 SLC22A3 ST3GAL4
Father's age at death 6.60 4 1 2.2 -1.00 1.1e-03 CDKN2B CDKN2B-AS1 FES PSRC1
Pulse rate 1.48 1 0 0.0 0.00 1.0e+00 SLC22A1
Medication: Ibuprofen (e.g. Nurofen) 3.85 2 1 2.2 0.00 1.0e+00 RP1-257A7.5 SLC22A3
Medication: Cholesterol lowering 20.05 8 4 8.9 0.92 1.3e-03 AIDA CDKN2B CDKN2B-AS1 FES PSRC1 SLC22A1 SLC22A3 ST3GAL4
Lung cancer (father) 4.84 3 0 0.0 0.00 1.0e+00 ADAMTS7 MORF4L1 NUDCD3
Illnesses of mother 4.40 2 1 2.2 0.00 1.0e+00 CDKN2B FES
Pulse wave Arterial Stiffness index 3.63 2 0 0.0 0.00 1.0e+00 FES RP1-257A7.5
Impedance of arm (left) 1.16 1 1 2.2 0.00 1.0e+00 SMG6
Arm fat mass (right) 1.44 3 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3 SMG6
Trunk predicted mass 1.37 3 2 4.4 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Standing height 0.61 3 1 2.2 0.00 1.0e+00 NUDCD3 PSRC1 SLC22A3
Breastfed as a baby 1.48 1 0 0.0 0.00 1.0e+00 FES
Hair/balding pattern: Pattern 4 1.30 1 0 0.0 0.00 1.0e+00 FES
Birth weight of first child 3.34 1 1 2.2 0.00 1.0e+00 FES
Medication: Paracetamol 2.03 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Headache pain in last month 4.28 2 1 2.2 0.00 1.0e+00 FES RP1-257A7.5
Medication for cholesterol, blood pressure or diabetes 9.67 3 2 4.4 0.00 1.0e+00 FES PSRC1 SLC22A1
Glaucoma (self-reported) 5.60 2 1 2.2 0.00 1.0e+00 CDKN2B CDKN2B-AS1
Medication: Amlodipine 3.28 1 1 2.2 0.00 1.0e+00 FES
Birth weight 1.92 1 1 2.2 0.00 1.0e+00 FES
Chronic bronchitis/emphysema (mother) 1.90 1 0 0.0 0.00 1.0e+00 MORF4L1
High blood pressure (siblings) 3.77 2 1 2.2 0.00 1.0e+00 FES SMG6
Body fat percentage 1.29 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Arm fat-free mass (right) 1.23 3 1 2.2 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Comparative body size at age 10 0.92 1 0 0.0 0.00 1.0e+00 SMG6
Pulse wave peak to peak time 3.57 2 0 0.0 0.00 1.0e+00 FES RP1-257A7.5
Medication for pain relief, constipation, heartburn 2.53 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Medication: Blood pressure 5.33 2 1 2.2 0.00 1.0e+00 FES SLC22A1
Angina (self-reported) 25.66 9 9 20.0 0.99 5.1e-08 ADAMTS7 CDKN2B CDKN2B-AS1 FES MORF4L1 PSRC1 RP1-257A7.5 SLC22A1 SLC22A3
Migraine (self-reported) 4.23 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Medication: Ibuprofen 3.93 2 1 2.2 0.00 1.0e+00 RP1-257A7.5 SLC22A3
Mean time to correctly identify matches 1.19 1 0 0.0 0.00 1.0e+00 FES
Heart disease (mother) 13.98 9 3 6.7 0.97 1.4e-05 ADAMTS7 CDKN2B CDKN2B-AS1 FES MORF4L1 RP1-257A7.5 SLC22A1 SLC22A3 ST3GAL4
Whole body fat mass 1.46 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Leg fat mass (right) 1.18 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Arm predicted mass (right) 1.22 3 0 0.0 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Pulse rate, automated reading 1.49 2 0 0.0 0.00 1.0e+00 AIDA RP1-257A7.5
Alcohol intake frequency. 1.82 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Comparative height size at age 10 0.88 3 0 0.0 0.00 1.0e+00 FES PSRC1 SLC22A3
Chest pain or discomfort 2.79 1 0 0.0 0.00 1.0e+00 CDKN2B
Medication: Aspirin 12.49 6 5 11.1 1.00 1.9e-05 CDKN2B CDKN2B-AS1 FES PSRC1 SLC22A1 SLC22A3
Hypertension (Self-reported) 5.96 2 1 2.2 0.00 1.0e+00 FES SMG6
Smoking status: Previous 1.98 1 0 0.0 0.00 1.0e+00 CDKN2B-AS1
Whole body fat-free mass 1.44 4 1 2.2 -0.49 5.1e-01 FES PSRC1 SLC22A3 SMG6
Leg fat-free mass (right) 1.56 5 1 2.2 -0.43 4.7e-01 FES NUDCD3 PSRC1 SLC22A3 SMG6
Arm fat percentage (left) 1.36 1 0 0.0 0.00 1.0e+00 NUDCD3
Handedness (chirality/laterality): Left-handed 1.60 1 0 0.0 0.00 1.0e+00 FES
Long-standing illness, disability or infirmity 1.43 1 0 0.0 0.00 1.0e+00 CDKN2B
Medication for cholesterol 6.13 3 1 2.2 0.00 1.0e+00 FES PSRC1 SLC22A3
Mineral and other dietary supplements 2.67 1 0 0.0 0.00 1.0e+00 FES
Breast cancer (self-reported) 2.49 1 0 0.0 0.00 1.0e+00 CDKN2B
Medication: Aspirin 12.75 6 5 11.1 1.00 1.1e-05 CDKN2B CDKN2B-AS1 FES PSRC1 SLC22A1 SLC22A3
Illnesses of father: None of the above (group 1) 10.51 5 2 4.4 -0.99 5.1e-04 CDKN2B CDKN2B-AS1 FES SLC22A3 ST3GAL4
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.22 3 0 0.0 0.00 1.0e+00 ADAMTS7 MORF4L1 NUDCD3
Whole body water mass 1.41 4 1 2.2 -0.50 5.0e-01 FES PSRC1 SLC22A3 SMG6
Leg predicted mass (right) 1.57 5 1 2.2 -0.43 4.7e-01 FES NUDCD3 PSRC1 SLC22A3 SMG6
Arm fat mass (left) 1.46 3 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3 SMG6
Number of self-reported non-cancer illnesses 3.11 1 0 0.0 0.00 1.0e+00 NUDCD3
Mother's age at death 2.02 1 0 0.0 0.00 1.0e+00 SLC22A1
Eye problems/disorders: Glaucoma 6.68 2 2 4.4 0.00 1.0e+00 CDKN2B CDKN2B-AS1
Medication: Blood pressure 5.60 4 1 2.2 0.86 1.4e-01 ADAMTS7 FES SLC22A3 SMG6
Supplements: Fish oil (including cod liver oil) 2.59 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
High cholesterol (Self-reported) 21.46 6 4 8.9 0.86 2.9e-02 FES NUDCD3 PSRC1 SLC22A1 SLC22A3 ST3GAL4
Medication: Bendroflumethiazide 3.76 2 1 2.2 0.00 1.0e+00 ADAMTS7 FES
Medication: Paracetamol 1.75 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Medication: Lisinopril 1.83 1 0 0.0 0.00 1.0e+00 FES
Medication: Atorvastatin 14.26 5 3 6.7 0.97 6.1e-03 CDKN2B CDKN2B-AS1 PSRC1 SLC22A1 SLC22A3
Illnesses of father: High blood pressure 4.27 1 1 2.2 0.00 1.0e+00 FES
Ever smoked 1.64 1 0 0.0 0.00 1.0e+00 FES
Basal metabolic rate 1.40 3 1 2.2 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Arm fat-free mass (left) 1.21 3 1 2.2 0.00 1.0e+00 PSRC1 SLC22A3 SMG6
Number of operations (self-reported) 2.02 1 0 0.0 0.00 1.0e+00 NUDCD3
Risk taking 2.17 1 0 0.0 0.00 1.0e+00 FES
Diastolic blood pressure, automated reading 6.99 6 3 6.7 -0.07 9.0e-01 ADAMTS7 CDH13 CDKN2B CDKN2B-AS1 FES MORF4L1
Vascular/heart problems diagnosed by doctor 7.11 4 1 2.2 -0.99 1.2e-02 FES SLC22A3 SMG6 ST3GAL4
Cholesterol lowering medication 11.17 4 2 4.4 0.90 9.6e-02 CDKN2B PSRC1 SLC22A1 SLC22A3
Pain experienced in last month 1.37 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Basal cell carcinoma (self-reported) 2.69 1 0 0.0 0.00 1.0e+00 CDKN2B
Heart attack/myocardial infarction (self-reported) 21.48 8 8 17.8 0.99 3.7e-06 AIDA CDKN2B CDKN2B-AS1 FES PSRC1 RP1-257A7.5 SLC22A1 SLC22A3
Heart disease (siblings) 11.45 8 1 2.2 0.98 1.3e-05 ADAMTS7 AIDA CDKN2B-AS1 FES PSRC1 RP1-257A7.5 SLC22A1 SLC22A3
Pack years of smoking 4.86 2 2 4.4 0.00 1.0e+00 ADAMTS7 MORF4L1
Impedance of whole body 1.64 1 1 2.2 0.00 1.0e+00 SMG6
Leg fat mass (left) 1.13 2 0 0.0 0.00 1.0e+00 NUDCD3 SLC22A3
Arm predicted mass (left) 1.24 3 0 0.0 0.00 1.0e+00 PSRC1 SLC22A3 SMG6

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 0 0.000 1.4
GTEx Adipose Visceral Omentum 1 0.049 1.4
GTEx Adrenal Gland 0 0.000 1.3
GTEx Artery Aorta 3 0.101 1.5
GTEx Artery Coronary 1 0.085 1.5
GTEx Artery Tibial 2 0.053 1.5
GTEx Brain Caudate basal ganglia 0 0.000 1.4
GTEx Brain Cerebellar Hemisphere 0 0.000 1.4
GTEx Brain Cerebellum 0 0.000 1.4
GTEx Brain Cortex 0 0.000 1.4
GTEx Brain Frontal Cortex BA9 1 0.108 1.5
GTEx Brain Hippocampus 0 0.000 1.4
GTEx Brain Hypothalamus 1 0.169 1.4
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.4
GTEx Brain Putamen basal ganglia 0 0.000 1.4
GTEx Breast Mammary Tissue 0 0.000 1.4
GTEx Breast Mammary Tissue (Male) 0 0.000 1.4
GTEx Breast Mammary Tissue (Female) 0 0.000 1.4
GTEx Cells EBV-transformed lymphocytes 1 0.070 1.4
GTEx Cells Transformed fibroblasts 2 0.048 1.4
GTEx Colon Sigmoid 1 0.068 1.4
GTEx Colon Transverse 0 0.000 1.3
GTEx Esophagus Gastroesophageal Junction 2 0.138 1.5
GTEx Esophagus Mucosa 1 0.030 1.4
GTEx Esophagus Muscularis 0 0.000 1.4
GTEx Heart Atrial Appendage 0 0.000 1.3
GTEx Heart Left Ventricle 0 0.000 1.4
GTEx Liver 1 0.139 1.5
GTEx Lung 1 0.035 1.4
GTEx Muscle Skeletal 2 0.069 1.4
GTEx Nerve Tibial 1 0.023 1.4
GTEx Ovary 0 0.000 1.5
GTEx Pancreas 0 0.000 1.4
GTEx Pituitary 0 0.000 1.4
GTEx Prostate 0 0.000 1.3
GTEx Skin Not Sun Exposed Suprapubic 0 0.000 1.4
GTEx Skin Sun Exposed Lower leg 3 0.082 1.4
GTEx Small Intestine Terminal Ileum 0 0.000 1.3
GTEx Spleen 0 0.000 1.3
GTEx Stomach 0 0.000 1.3
GTEx Testis 0 0.000 1.3
GTEx Thyroid 1 0.025 1.4
GTEx Uterus 0 0.000 1.5
GTEx Vagina 0 0.000 1.3
GTEx Whole Blood 3 0.151 1.4
METSIM Adipose 2 0.043 1.4
NTR Blood 0 0.000 1.4
ROSMAP Brain Pre-frontal Cortex 3 0.068 1.4
YFS Blood 2 0.043 1.4
CommonMind Brain Pre-frontal Cortex 4 0.074 1.4
The Cancer Genome Atlas Bladder Urothelial Carcinoma 2 0.121 1.3
The Cancer Genome Atlas Breast Invasive Carcinoma 3 0.068 1.4
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 1 0.091 1.4
The Cancer Genome Atlas Colon Adenocarcinoma 4 0.194 1.5
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Glioblastoma Multiforme 1 0.098 1.5
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 1 0.037 1.4
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 1 0.024 1.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 2 0.098 1.5
The Cancer Genome Atlas Brain Lower Grade Glioma 1 0.023 1.4
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 2 0.181 1.5
The Cancer Genome Atlas Lung Adenocarcinoma 1 0.034 1.4
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 1 0.040 1.4
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 2 0.126 1.4
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.3
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 0 0.000 1.4
The Cancer Genome Atlas Prostate Adenocarcinoma 3 0.065 1.4
The Cancer Genome Atlas Rectum Adenocarcinoma 0 0.000 1.3
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.5
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.5
The Cancer Genome Atlas Stomach Adenocarcinoma 1 0.059 1.4
The Cancer Genome Atlas Testicular Germ Cell Tumors 1 0.078 1.4
The Cancer Genome Atlas Thyroid Carcinoma 1 0.019 1.4
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.4